• Accueil >
  • Publications >
  • Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab

Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab

1 janv. 2017Annals of Oncology

DOI : 10.1093/annonc/mdw535

Auteurs

J.-Y. Pierga, F.-C. Bidard, A. Autret, T. Petit, F. Andre, F. Dalenc, C. Levy, J.-M. Ferrero, G. Romieu, J. Bonneterre, F. Lerebours, T. Bachelot, P. Kerbrat, M. Campone, J.-C. Eymard, M.-A. Mouret-Reynier, J. Gligorov, A.-C. Hardy-Bessard, A. Lortholary, P. Soulie, J.-M. Boher, C. Proudhon, E. Charafe-Jaufret, J. Lemonnier, F. Bertucci, P. Viens